OralID is an adjunctive aid to the standard of care visual and palpation exam. The OralID device uses fluorescence technology, which provides additional information on the health of the tissue that may not be seen by the naked eye. With no consumables, the device requires zero per patient costs. OralID is the currently the most affordable device on the oral cancer screening market.
OralID is manufactured by Forward Science, a company that was founded with the vision to create a simpler, efficient and more affordable oral screening device that can save more lives. OralID uses the same proven fluorescence technology as other oral exam devices, but costs up to fifty percent less than its closest competitor (and only one-third of another competitor). However, unlike any other device on the market, OralID has no per-patient cost during use. The combination of OralID's comparatively low initial investment cost and a lack of disposables mean OralID is the oral exam device that every clinician deserves to wield in the fight against oral cancer.
QUESTIONS & ANSWERS